Menu Search
Equities

Canatu Oyj

0CD:FRA

Canatu Oyj

Actions
  • Price (EUR)12.40
  • Today's Change0.00 / 0.00%
  • Shares traded45.00
  • 1 Year change+30.80%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Canatu Oyj, formerly known as Lifeline SPAC I Oyj, is a Finland-based carbon nanomaterial developer. The Company manufactures advanced carbon nanotubes and semiconductors for the automotive industry. The Company's manufacturing process enables the production of longer and cleaner nanotubes, minimizing the amount of CNT junctions. This results in higher electrical and thermal conductivity. The Company's main focus is on the automotive and semiconductor industries with the offering for medical diagnostics. The Company also provides electrochemical sensors to be used for diverse applications in various industries, such as medical diagnostics, veterinary care, environmental monitoring, food & beverages, and industrial processes

  • Revenue in EUR (TTM)0.00
  • Net income in EUR1.94m
  • Incorporated2021
  • Employees--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.